ADVANZ PHARMA Holdco Limited a UK headquartered global pharmaceutical company with a strategic focus on speciality, hospital, and rare disease medicines today announced the expansion of its specialty brands portfolio with the acquisition of certain APAC (excluding Japan and China) rights of Progynova® and Cyclo-Progynova® from Bayer.Progynova is an oral hormone replacement therapy to treat signs and symptoms of estrogen deficiency and/or to prevent post-menopausal osteoporosis.

总部位于英国的全球性制药公司ADVANZ PHARMA Holdco Limited今天宣布，通过收购拜耳公司Progynova®和Cyclo-Progynova®的某些亚太地区（不包括日本和中国）权利，扩大其专业品牌组合。ADVANZ PHARMA Holdco Limited是一家战略性专注于专业、医院和罕见病药物的全球制药公司。Progynova是一种口服激素替代疗法，用于治疗雌激素缺乏的体征和症状和/或预防绝经后骨质疏松症。

Cyclo-Progynova* is a menstrual regulator for women of any age.**ADVANZ PHARMA continues leveraging its commercial footprint and global partner network to bring specialty medicines to patients worldwide. The transaction follows the announcement in October 2023 that ADVANZ PHARMA signed an agreement to acquire Progynova® and Cyclo-Progynova® in selected countries in LATAM from Bayer.* Cyclo-Progynova uses Progyluton as trade name in certain countries (Afghanistan, Cambodia, Malaysia, Pakistan and Singapore).** Indications vary by market, strength, and form.

Cyclo Progynova*是任何年龄段女性的月经调节剂。**ADVANZ PHARMA继续利用其商业足迹和全球合作伙伴网络，为全球患者带来专业药物。2023年10月，ADVANZ PHARMA宣布签署协议，从拜耳手中收购拉坦选定国家的Progynova®和Cyclo-Progynova®。*Cyclo-Progynova在某些国家（阿富汗、柬埔寨、马来西亚、巴基斯坦和新加坡）使用Progyluton作为商品名适应症因市场、实力和形式而异。

For local indications please check the local approved label.About ADVANZ PHARMAPartner of choice in specialty, hospital, and rare disease medicinesADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing and enhancing the specialty, hospital, and rare disease medicines they depend on.

对于当地适应症，请检查当地批准的标签。关于ADVANZ PHARMAPartner专业、医院和罕见病药物的首选Vanz PHARMA是一家全球性制药公司，旨在通过提供和改进患者所依赖的专业、医院和罕见病药物来改善患者的生活。

Our headquarters are in London, UK. We have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe, the US, Canada, and Australia, a Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network.

我们的总部位于英国伦敦。我们在全球90多个国家进行商业销售，并在20多个国家直接开展商业活动，包括欧洲、美国、加拿大和澳大利亚的关键国家，印度孟买的卓越中心，以及已建立的全球分销和商业化合作伙伴网络。

ADVANZ PHARMA’s product portfolio and pipeline comprises innovativ.

ADVANZ PHARMA的产品组合和管道包括innovativ。